Career Center

SoMCC Event

Title:

Industry Insights: The Road to Personalized Medicine with 23andMe

Date: May 12, 2009
Time: 12:00-1:30 PM
Location: M-106 Classroom, School of Medicine

Sponsor: SoMCC

Event details:

Overview:
With the advent of the Human Genome Project came the birth of a new term and lifestyle: personalized medicine, which promises to provide better care by analyzing the genetic basis of a disease and tailoring the treatment to the individual.  As the science of genomics continues to improve, the implications could radically change the medical world and will confront us with many questions about the relationship between science and society.  How will these advances affect policy, research, medicine, and most importantly, each one of us? 

By helping people access and interpret their own genetic data, 23andMe is at the forefront of this scientific revolution and is focused on empowering individuals with the knowledge of their own DNA.  Co-founded by Linda Avey, 23andMe is attempting to conduct research under a new model that will tackle the current limits to the potential of high-density genome-wide scanning technologies and will accelerate the pace at which personalized medicine becomes a reality.   
 
About our Presenter:  
Linda Avey has over 20 years of sales and business development experience in the biopharmaceutical industry in San Francisco, Boston, San Diego, and Washington, D.C. Prior to starting 23andMe, she developed translational research collaborations with academic and pharmaceutical partners for Affymetrix and Perlegen Sciences. Linda also spent time at Spotfire helping scientists understand the power of data visualization and at Applied Biosystems during the early days of the human genome project. The advent of high density genome-wide scanning technologies brought huge potential for significant discoveries. However, the lack of sufficient funding to enable adequate studies prompted Linda to think of a new research model. These ideas led to the formation of 23andMe. Her primary interest is the acceleration of personalized medicine, using genetic profiles to target the right drug to the right person at the correct dose. Linda graduated from Augustana College with a B.A. in biology.

Fee: Free and open to Stanford ID holders.
Additional information and/or registration: RSVP required. Register online

Stanford Medicine Resources:

Footer Links: